Mar 18

NMIBC Treatment Landscape (Republished)

NMIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Janet Kukreja, MD, MPH, FACS CME Available: https://cme.auanet.org/URL/GUPOD253 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: AstraZeneca Johnson & Johnson LEARNING OB ... Show More

29m 31s

Mar 11

MIBC Treatment Landscape (Republished)

MIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Jen-Jane Liu, MD, FACS CME Available: https://cme.auanet.org/URL/GUPOD252 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: AstraZeneca Johnson & Johnson LEARNING OBJECTIVE ... Show More

24m 27s

Mar 4

AUA2025: Key Takeaways: Bladder Cancer

AUA2025: Key Takeaways: Bladder Cancer Presenters: Patrick Hensley, MD & Janet Kukreja, MD

23m 12s

Sep 2025

Prostate Cancer

Send a textNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob break down the essential clinical and pathophysiologic features of Prostate Cancer, one of the most common malignancies affecting men worldwide.We begin with the epidemiology and risk factors, highligh ... Show More

34m 59s

Oct 2024

Quality of life for mPCa patients undergoing treatment

In this interview recorded at UROonco24 in Budapest earlier in the year, Dr. Gianluca Giannarini (IT) talks with Prof. Geert De Meerleer (BE) about the quality of life for patients with metastatic prostate cancer (mPCa) that are undergoing treatment. Their conversation feature ... Show More

10m 26s

May 2023

AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis

Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ... Show More

51m 37s

Jul 2024

#310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.

<a href= "https://peterattiamd.com/TedSchaeffer3/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=240722-pod-TedSchaeffer3&utm_content=240722-pod-TedSchaeffer3-podfeed"> View the Show Notes Page for This Episode</a> <a href= "https://peterattiamd.com/subscribe/ ... Show More

47m 53s

Feb 2023

206. #PROSTATE PRISE EN CHARGE DES FISTULES URÉTRO-RECTALES APRÈS UN CANCER DE LA PROSTATE LOCALISÉ - DOCTEUR PAUL NEUVILLE

206. #PROSTATE PRISE EN CHARGE DES FISTULES URÉTRO-RECTALES APRÈS UN CANCER DE LA PROSTATE LOCALISÉ - DOCTEUR PAUL NEUVILLELa fistule urétro-rectale après prostatectomie appartient-elle au passé ?Peut-on réaliser un traitement conservateur et comment ?Quelle prise en charge chiru ... Show More

6m 37s

Jul 2024

18F-PSMA-1007 PET/CT - Sponsored by Mayo Clinic

Dr. Ashwin Singh Parihar discusses the role of multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer with Dr. Bastiaan Privé. This episode is sponsored by Mayo Clinic. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detectio ... Show More

18m 6s

Nov 2022

197. #PROSTATE COMMENT MIEUX PRENDRE EN CHARGE LA QUALITÉ DE VIE D'UN PATIENT TRAITÉ PAR HORMONOTHÉRAPIE POUR UN CANCER DE LA PROSTATE ? - DOCTEUR JONATHAN OLIVIER

Comment mieux prendre en charge la qualité de vie d'un patient traité par hormonothérapie pour un cancer de prostate ?Quelles sont les effets indésirables de l’hormonothérapie ?Comment prendre en charge les risques de complication cardiovasculaire et les risques d’osthéoporose ?C ... Show More

6m 49s

Sep 2024

ESMO 2024 special: Results of interim analysis of SunRISe-4

UROONCO BCa chief editor Dr. Benjamin Pradere talks to Assoc. Prof. Andrea Necchi (IT) at EMSO 2024 on the results of the interim analysis of SunRISe-4 study: TAR-200 plus cetrelimab or CET alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are in ... Show More

10m 22s

Jul 2024

Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More

57m 23s

Oct 2024

393. SGLT Inhibitors: Clinical Implementation of SGLT Inhibitors with Dr. Alison Bailey

CardioNerds Drs. Jason Feinman, Gurleen Kaur, and Rick Ferraro discuss the implementation of SGLT inhibitors in clinical practice with Dr. Alison Bailey. Notes were drafted by Dr. Jason Feinman. In this episode, we discuss the implementation of SGLTi in clinical practice scenario ... Show More

19m 21s

PARP Inhibitors in Advanced Prostate Can...